Suggested mechanisms of action of UVA phototherapy in morphea: A molecular study

Photodermatology Photoimmunology and Photomedicine

Volumn 20, Issue 2, 2004, Pages 93-100

  El Mofty, M ^a   Mostafa, W ^a   Esmat, S ^a   Youssef, R ^a   Bousseila, M ^a   Nagi, N ^a   Shaker, O ^a   Abouzeid, A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Collagen I; Collagen III; Collagenase; INF ; Scleroderma; TGF ; UVA

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE; GAMMA INTERFERON; INTERSTITIAL COLLAGENASE; PARAFFIN; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HARDNESS; HUMAN; HUMAN TISSUE; LOW ENERGY RADIATION; MALE; MORPHEA; PHOTOTHERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION RESPONSE; SCLERODERMA; SKIN BIOPSY; SKIN DEFECT; STATISTICAL SIGNIFICANCE; ULTRAVIOLET A RADIATION;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CHILD; COLLAGEN; COLLAGENASES; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SCLERODERMA, LOCALIZED; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 1842536514     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2004.00080.x     Document Type: Article

References (29)

1. Trojanowska M. Molecular aspects of scleroderma. Front Biosci 2002; 7: D608-d618.
2. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995; 70: 1068-1076.
3. Tu H, Eisen AZ. Scleroderma. In: Freedberg M, Eisen AZ, Wolf K, Frank Austen K, Goldsmith LA, Katz SI, Fitzpatric TB, eds. Fitzpatrick's dermatology in general medicine, 5. New York: McGraw-Hill, 1999: P 2023.
4. Freundlich B, Jimenez SA, Steen VD, Medsger TA Jr, Szkolnicki M, Jaffe HS. Treatment of systemic sclerosis with recombinant interferon-gamma. A phase I/II clinical trial. Arthritis Rheum 1992; 35: 1134-1142.
5. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997; 36 (Part 1): 938-944.
6. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997; 350: 1295-1296.
7. Kerscher M, Volkenandt M, Gruss C, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998; 38: 21-26.
8. Polderman MC, Pavel S, Vermeer BJ, Wintzen M. Ultraviolet A-I phototherapy for skin diseases. Ned Tijdschr Geneeskd 1999; 143: 931-934.
9. Dutz J. Treatment options for the cutaneous manifestations of systemic sclerosis. Skin Therapy Lett 2000; 6: 3-5.
10. Gruss CJ, Von Kobyletzki G, Behrens-Williams SC, et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed 2001; 17: 149-155.
11. Camacho NR, Sanchez JE, Martin RF, Gonzalez JR, Sanchez JL. Medium-dose UVA1 phototherapy in localized scleroderma and its effect on CD34-positive dendritic cells. J Am Acad Dermatol 2001; 45: 697-699.
12. El-Mofty M, Zaher H, Bosseila M, Yousef R, Saad B. Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed 2000; 16: 43-49.
13. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 1994; 103: 359-363.
14. Quan T, He T, Voorhees JJ, Fisher GJ. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7. J Biol Chem 2001; 276: 26349-26356.
15. Reeve VE, Bosnic M, Nishimura N. Interferon-gamma is involved in photoimmunoprotection by UVA (320-400 nm) radiation in mice. J Invest Dermatol 1999; 112: 945-950.
16. Zheng P, Kligman LH. UVA-induced ultrastructural changes in hairless mouse skin: A comparison to UVB-induced damage. J Invest Dermatol 1993; 100: 194-199.
17. Pascual-Le Tallec L, Korwin-Zmijowska C, Adolphe M. Effects of simulated solar radiation on type I and type III collagens, collagenase (MMP-1) and stromelysin (MMP-3) gene expression in human dermal fibroblasts cultured in collagen gels. J Photochem Photobiol B 1998; 42: 226-232.
18. Menter JM, Patta AM, Sayre RM, Dowdy J, Willis I. Effect of UV irradiation on type I collagen fibril formation in neutral collagen solutions. Photodermatol Photoimmunol Photomed 2001; 17: 114-120.
19. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987; 6: 1899-1904.
20. Yamamoto T, Eckes B, Krieg T. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: Differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun 2001; 281: 200-205.
21. Vuorio T, Kahari VM, Black C, Vuorio E. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. J Rheumatol 1991; 18: 247-251.
22. Lee HS, Kooshesh F, Sauder DN, Kondo S. Modulation of TGF-beta 1 production from human keratinocytes by UVB. Exp Dermatol 1997; 6: 105-110.
23. Dissanayake NS, Mason RS. Modulation of skin cell functions by transforming growth factor-beta 1 and ACTH after ultraviolet irradiation. J Endocrinol 1998; 159: 153-163.
24. Kahari VM, Heino J, Vuorio T, Vuorio E. Interferon-alpha and interferon-gamma reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture. Biochim Biophys Acta 1988; 968: 45-50.
25. Gillery P, Serpier H, Polette M, et al. Gamma-interferon inhibits extra cellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblast. Eur J Cell Biol 1992; 57: 244-253.
26. Kikuchi K, Kadono T, Fujimoto M, Ihn H, Sato S, Takehara K. Elevated procollagen type I carboxyterminal propeptide production in cultured scleroderma fibroblasts. Dermatology 1995; 190: 104-108.
27. Hunzelmann N, Anders S, Fierlbeck G, et al. Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma. J Am Acad Dermatol 1997; 36 (Part 1): 433-435.
28. Shen J, Bao S, Reeve VE. Modulation of IL-10, IL-12, and IFN-gamma in the epidermis of hairless mice by UVA (320-400 nm) and UVB (280-320 nm) radiation. J Invest Dermatol 1999; 113: 1059-1064.
29. Coulomb B, Lebreton C, Mathieu N, Morhere P. UVA-induced oxidative damage in fibroblasts cultured in a 3-dimensional collagen matrix. Exp Dermatol 1996; 5: 161-167.